Notice of Special Interest (NOSI): Research Related to Neuroethical Considerations for Neurological Diseases (NOT-NS-24-073)

Sponsor: National Institute of Neurological Disorders and Stroke

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) (PA-24-246)

Sponsor: National Institutes of Health, Centers for Disease Control and Prevention

Due Date: Multiple due dates; see announcement.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) (PA-24-247)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) (PA-24-248)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-24-245)

Sponsor: National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration

Due Date: Multiple due dates; see announcement.

2025 Tauopathy Challenge Workshop

Sponsor: The Rainwater Charitable Foundation

Award: Workshop participants will be selected through a competitive Letter of Intent process. Up to 12 participants will be selected to attend the workshop and each attendee will receive a $10,000 grant to support their laboratory research. Travel and lodging expenses will also be covered. Following the meeting, workshop attendees can apply for research grants providing up to $500,000 over two years; up to four awards will be funded, pending budget availability.

Due Date: Letter of Intent Deadline: August 15, 2024.

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) (PAR-24-228)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Required) (PAR-24-229)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (PAR-24-212)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Due Date: Multiple due dates; see announcement.

NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed) (PAR-24-213)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Due Date: Multiple due dates; see announcement.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (PAR-24-223)

Sponsor: National Institute on Aging

Award: Application budgets are limited to $1,500,000 in direct costs per year. For Early Stage projects, the project period is limited to five years. For Late Stage projects, the project period is limited to four years.

Due Date: Multiple due dates; see announcement.

Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (PAR-24-204)

Sponsor: National Institutes of Health

Award: A project period of up to five years may be requested. Funds may be requested for a minimum of 8 weeks and a maximum of 15 weeks of research education experience each year. Proposed, budgets cannot exceed $125,000 direct costs per year.

Due Date: Multiple due dates; see announcement.

Treat FTD Fund

Sponsor: The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD)

Award: Up to $2,500,000 over 1 – 3 years, based on stage and scope of the trial.

Due Date: Letter of Intent due September 30th, 2024. Full Proposal due December 9th, 2024.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional) (RFA-DA-24-040)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed) (RFA-DA-24-041)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.